Definitive Healthcare Corp Dossier - Source-backed chat

Definitive Healthcare Corp

DHNASDAQ

SectorHealth Care

IndustryHealth Care Technology

Beta (adjusted)1.23

Intrinsic Value

No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference.

Market Price $0.94Price as of 1 Oct 2026

Data confidence Sign in to view data confidence

Market Cap $99.9M

Enterprise Value $89.7M

Shares Outstanding 102.1M diluted

Moat Rating None

Next Earnings Date5 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Definitive Healthcare Corp. (DH) is facing severe structural headwinds characterized by accelerating customer churn, deteriorating net dollar retention (NDR), and consecutive years of massive goodwill impairments that have fully written off its goodwill to zero. While the company maintains non-GAAP profitability and disciplined expense management, its core SaaS business model is contracting. The exit of major private equity sponsor Spectrum Equity below the 5% threshold further signals a lack of institutional confidence. Optically cheap valuation multiples do not represent a margin of safety given the guided 6% to 9% revenue decline for FY 2026.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets6 analysts · as of 18 Aug 2026

Low · most bearish analyst$0.70

Mean target$2.20

High · most bullish analyst$3.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$1.0030%

The bear case is driven by an acceleration of enterprise customer churn (ARR > $100k) and a failure of the AI product roadmap to drive meaningful upsells, causing NDR to drop below 80%. Continued contraction in the core subscription business, combined with negative operating leverage from a largely fixed cost structure, would severely compress EBITDA margins and erode free cash flow generation, pushing the stock toward its historical lows.

Base CaseCentral scenario

$2.2055%

Matches the consensus mean

The base case assumes that top-line pressures persist throughout 2026, with FY 2026 revenue declining by 6% to 9% to a range of $220M - $226M, in line with management guidance. Customer churn, particularly among smaller and life sciences clients, continues to offset new logo acquisitions. However, disciplined cost management preserves Adjusted EBITDA margins in the 25% - 26% range, and the company continues to generate positive unlevered free cash flow.

Bull CaseUpside scenario

$3.5025%

The bull case relies on a successful stabilization of the customer base, driven by the launch of new AI-enabled solutions and faster integration times (reduced to ~45 days). If the company can successfully cross-sell these new features, NDR could recover back toward 90%, and professional services could continue their double-digit growth trajectory, leading to a return to positive top-line growth by late 2026 or early 2027.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong non-GAAP profitability with Adjusted EBITDA margins maintained at 25% - 27% through disciplined cost control.
Consistent positive cash flow generation, with $18 million of unlevered free cash flow in Q1 2026 and nearly $50 million on a TTM basis.
Operational improvements in data integration times, which have been cut to approximately 45 days.

Key Investment Risks

Accelerating customer churn, with total customers declining by 70 and enterprise customers declining by 16 in Q1 2026 alone.
Deteriorating Net Dollar Retention (NDR), which fell to 81% overall and 85% for enterprise customers in 2025.
Sustained top-line contraction, with management guiding for a 6% to 9% revenue decline in FY 2026.
Loss of institutional sponsor support, highlighted by Spectrum Equity's exit from the board after dropping below 5% ownership.

Thesis Invalidation Triggers

An unexpected inflection in quarterly revenue growth to positive year-over-year territory.
A sequential increase in Net Dollar Retention (NDR) back above 85% in upcoming quarters.
A significant stabilization or net addition of enterprise customers (ARR > $100k).

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.